Novo Nordisk A/S ADR buy Argus
Start price
10.06.24
/
50%
€132.00
Target price
10.06.25
€148.83
Performance (%)
-1.89%
Price
16.07.24
€129.50
Summary
This prediction is currently active. With a performance of -1.89%, the BUY prediction by Argus is trending in the wrong direction. This prediction currently runs until 10.06.25. The prediction end date can be changed by Argus at any time. Argus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novo Nordisk A/S ADR | -0.385% | -0.385% |
iShares Core DAX® | 1.776% | 3.175% |
iShares Nasdaq 100 | -1.037% | 1.869% |
iShares Nikkei 225® | -0.335% | 3.857% |
iShares S&P 500 | 0.854% | 2.567% |
Comments by Argus for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target raised by analysts at Argus from $125.00 to $160.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by Argus for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€85.60
02.10.23
02.10.23
€104.76
02.10.24
02.10.24
52.00%
16.07.24
16.07.24